Intech Investment Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Intech Investment Management LLC

$8.75 Billion
Q3 2024

A detailed history of Intech Investment Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 11,903 shares of REGN stock, worth $8.99 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

11,903

Previous 15,143 21.4%

Holding current value

$8.99 Million

Previous $15.9 Million 21.38%

% of portfolio

0.14%

Previous 0.2%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$1024.09 - $1201.76 $3.32 Million - $3.89 Million	-3,240 Reduced 21.4%	11,903 $12.5 Million
Q2 2024 Aug 12, 2024	BUY	$883.2 - $1071.19 $1.98 Million - $2.4 Million	2,245 Added 17.41%	15,143 $15.9 Million
Q1 2024 May 10, 2024	SELL	$902.69 - $993.35 $5.14 Million - $5.66 Million	-5,695 Reduced 30.63%	12,898 $12.4 Million
Q4 2023 Oct 18, 2024	BUY	$775.18 - $881.7 $7.83 Million - $8.91 Million	10,104 Added 119.02%	18,593 $16.3 Million
Q4 2023 Feb 09, 2024	BUY	$775.18 - $881.7 $7.83 Million - $8.91 Million	10,104 Added 119.02%	18,593 $16.3 Million
Q3 2023 Oct 18, 2024	BUY	$692.45 - $844.37 $1.79 Million - $2.18 Million	2,582 Added 43.71%	8,489 $6.99 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $1.67 Million - $2.04 Million	2,417 Added 39.81%	8,489 $6.99 Million
Q2 2023 Oct 18, 2024	SELL	$700.03 - $830.35 $23.1 Million - $27.4 Million	-33,018 Reduced 84.82%	5,907 $4.24 Million
Q2 2023 Aug 09, 2023	SELL	$700.03 - $830.35 $23 Million - $27.3 Million	-32,853 Reduced 84.4%	6,072 $4.36 Million
Q1 2023 Oct 18, 2024	BUY	$680.49 - $826.97 $16.2 Million - $19.7 Million	23,782 Added 157.05%	38,925 $32 Million
Q1 2023 May 10, 2023	SELL	$680.49 - $826.97 $8.14 Million - $9.89 Million	-11,962 Reduced 23.51%	38,925 $32 Million
Q4 2022 Oct 18, 2024	BUY	$705.89 - $766.39 $4.94 Million - $5.36 Million	7,000 Added 16.03%	50,676 $36.6 Million
Q4 2022 Feb 09, 2023	BUY	$705.89 - $766.39 $5.09 Million - $5.53 Million	7,211 Added 16.51%	50,887 $36.7 Million
Q3 2022 Oct 18, 2024	BUY	$573.97 - $724.32 $16.4 Million - $20.7 Million	28,533 Added 188.42%	43,676 $30.1 Million
Q3 2022 Nov 10, 2022	SELL	$573.97 - $724.32 $2.7 Million - $3.4 Million	-4,700 Reduced 9.72%	43,676 $30.1 Million
Q2 2022 Aug 10, 2022	BUY	$548.35 - $738.84 $26.5 Million - $35.7 Million	48,376 New	48,376 $28.6 Million

Others Institutions Holding REGN

# of Institutions

1,532

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $80.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.

Account

Intech Investment Management LLC Regeneron Pharmaceuticals, Inc. Transaction History